Fagotti, Anna
 Distribuzione geografica
Continente #
NA - Nord America 11.802
AS - Asia 10.693
EU - Europa 9.510
SA - Sud America 2.584
AF - Africa 307
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 16
Totale 34.951
Nazione #
US - Stati Uniti d'America 11.401
SG - Singapore 5.487
CN - Cina 2.428
DE - Germania 2.163
BR - Brasile 2.154
SE - Svezia 1.754
IT - Italia 1.700
FR - Francia 641
IN - India 638
IE - Irlanda 608
VN - Vietnam 573
UA - Ucraina 530
PL - Polonia 469
GB - Regno Unito 467
ID - Indonesia 410
FI - Finlandia 323
RU - Federazione Russa 277
HK - Hong Kong 196
CA - Canada 168
AR - Argentina 163
BD - Bangladesh 136
MX - Messico 136
TR - Turchia 127
JP - Giappone 122
NL - Olanda 110
IQ - Iraq 105
KR - Corea 94
ZA - Sudafrica 84
AT - Austria 76
BE - Belgio 72
ES - Italia 69
EC - Ecuador 65
CI - Costa d'Avorio 50
CZ - Repubblica Ceca 50
PK - Pakistan 45
CO - Colombia 41
MA - Marocco 41
VE - Venezuela 40
SA - Arabia Saudita 39
IR - Iran 36
KE - Kenya 34
PY - Paraguay 34
UZ - Uzbekistan 33
CH - Svizzera 28
EG - Egitto 28
CL - Cile 27
LT - Lituania 26
AU - Australia 25
PH - Filippine 23
PE - Perù 22
RO - Romania 22
AE - Emirati Arabi Uniti 21
IL - Israele 21
UY - Uruguay 21
JO - Giordania 20
KZ - Kazakistan 17
OM - Oman 16
JM - Giamaica 15
HU - Ungheria 14
MY - Malesia 14
HN - Honduras 13
AZ - Azerbaigian 12
GR - Grecia 12
PA - Panama 12
PT - Portogallo 12
BZ - Belize 11
HR - Croazia 11
TT - Trinidad e Tobago 11
BG - Bulgaria 10
BO - Bolivia 10
DO - Repubblica Dominicana 10
DZ - Algeria 10
KG - Kirghizistan 10
NZ - Nuova Zelanda 10
AL - Albania 9
EU - Europa 9
TN - Tunisia 9
DK - Danimarca 8
ET - Etiopia 8
LV - Lettonia 8
NP - Nepal 8
CR - Costa Rica 7
LB - Libano 7
SK - Slovacchia (Repubblica Slovacca) 7
SN - Senegal 7
AM - Armenia 6
AO - Angola 6
BH - Bahrain 6
NI - Nicaragua 6
NO - Norvegia 6
PS - Palestinian Territory 6
RS - Serbia 6
TW - Taiwan 6
LA - Repubblica Popolare Democratica del Laos 5
LK - Sri Lanka 5
MD - Moldavia 5
MN - Mongolia 5
NG - Nigeria 5
XK - ???statistics.table.value.countryCode.XK??? 4
BY - Bielorussia 3
Totale 34.870
Città #
Singapore 2.613
Chandler 2.054
Ashburn 1.214
Dublin 601
Beijing 565
Warsaw 415
San Mateo 401
New York 382
Jakarta 375
Rome 373
Los Angeles 334
Hyderabad 333
Jacksonville 298
Wilmington 288
Hefei 282
Frankfurt am Main 273
Boston 265
Ann Arbor 258
Milan 239
Nanjing 210
Dallas 206
Ho Chi Minh City 205
Houston 191
Princeton 184
Hong Kong 182
Woodbridge 180
Moscow 178
São Paulo 172
Fairfield 159
Munich 158
Marseille 156
Dearborn 147
Hanoi 147
Seattle 129
Cattolica 126
Helsinki 126
Nürnberg 105
Redwood City 99
Lawrence 97
The Dalles 97
Tokyo 97
Buffalo 94
Seoul 86
Boardman 85
Rio de Janeiro 85
Chicago 79
Kent 75
Nuremberg 74
Santa Clara 73
London 71
Nanchang 66
Brussels 65
Brooklyn 60
Bremen 55
Mountain View 54
Düsseldorf 53
Hangzhou 53
Atlanta 51
Belo Horizonte 51
Abidjan 50
Izmir 50
San Francisco 50
Johannesburg 49
Kunming 49
Lappeenranta 49
Vienna 48
Amsterdam 47
Brasília 46
Phoenix 46
Toronto 46
Cambridge 44
Denver 44
Montreal 44
Norwalk 44
Turku 42
Zhengzhou 42
Leawood 41
Baghdad 40
Mexico City 40
Dhaka 39
Guangzhou 39
Orem 39
Shanghai 39
Augusta 38
Poplar 37
Stockholm 37
Fuzhou 36
Chennai 35
Salvador 35
Hebei 34
Tianjin 33
Nairobi 32
Shenyang 32
Changsha 31
Detroit 31
Pune 31
Manchester 30
Porto Alegre 30
Redmond 30
Tashkent 30
Totale 17.773
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 835
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 347
Laparoendoscopic Single-Site Surgery (LESS) for Treatment of Benign Adnexal Disease: Single-Center Experience Over 3-Years 333
A randomized study comparing the use of the Ligaclip with bipolar energy to prevent lymphocele during laparoscopic pelvic lymphadenectomy for gynecologic cancer. 272
Elderly and very elderly advanced ovarian cancer patients: Does the age influence the surgical management? 269
Nutritional Interventions to Improve Clinical Outcomes in Ovarian Cancer: A Systematic Review of Randomized Controlled Trials. 265
Clinical impact of SARS-CoV-2 infection among patients with vulvar cancer: the Gemelli Vul.Can multidisciplinary team 233
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 204
Total laparoscopic hysterectomy in early-stage endometrial cancer using an intrauterine manipulator: is it a bias for frozen section analysis? Case-control study 200
The impact of surgical delay on resectability of colorectal cancer: An international prospective cohort study 197
Laparoscopic staging of apparent early stage ovarian cancer: results of a large, retrospective, multi-institutional series 197
Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery 193
Delaying surgery for patients with a previous SARS-CoV-2 infection 187
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 183
Advanced vulvar carcinoma: is it worth operating? A perioperative management protocol for radical and reconstructive surgery 176
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study 175
Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data 174
Urologic surgery in gynecologic oncology: a large single-institution experience 173
The sonographic prediction of invasive carcinoma in unilocular-solid ovarian cysts in premenopausal patients: a pilot study. 171
Laparoscopic, minilaparoscopic and single-port hysterectomy: perioperative outcomes 168
Secondary cytoreductive surgery in patients with isolated platinum-resistant recurrent ovarian cancer: A retrospective analysis 167
Should laparoscopy be included in the work-up of advanced ovarian cancer patients attempting interval debulking surgery? 164
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience. 163
Influence of Intraperitoneal Dissemination Assessed by Laparoscopy on Prognosis of Advanced Ovarian Cancer: An Exploratory Analysis of a Single-Institution Experience 162
Learning a new robotic surgical device: Telelap Alf X in gynaecological surgery 159
Elective Cancer Surgery in COVID-19-Free Surgical Pathways during the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study 158
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? 157
Neoadjuvant chemotherapy followed by conization in stage IB2–IIA1 cervical cancer larger than 2 cm: a pilot study 156
A laparoscopic risk-adjusted model to predict major complications after primary debulking surgery in ovarian cancer: A single-institution assessment 153
Teaching and training in laparoscopic surgery: experience of Catholic Laparoscopy Advanced Surgery School in the basic gynecological surgery 151
Sexual and reproductive outcomes in early stage cervical cancer patients after excisional cone as a fertility-sparing surgery: An italian experience 149
Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome. 147
Rectosigmoid Mesorectal-Sparing Resection in Advanced Ovarian Cancer Surgery 146
Fusion imaging in the preoperative assessment of the extension of disease in patients with advanced ovarian cancer: feasibility and agreement with laparoscopic findings 143
Excisional cone as fertility-sparing treatment in early-stage cervical cancer. 142
Ultrasound evaluation of intra-abdominal sites of disease to predict the likelihood of suboptimal cytoreduction in advanced ovarian cancer: a propective study 138
Hyperthermic intraperitoneal chemotherapy in interval debulking surgery for advanced epithelial ovarian cancer: A single-center, real-life experience 137
Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments 134
Importance of a specialized pathologist for the examination of frozen sections of adnexal masses. 132
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience 132
Oncologic and obstetric outcomes after simple conization for fertility-sparing surgery in FIGO 2018 stage IB1 cervical cancer 132
Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study 131
Molecular profile of brca-negative long survivor high grade serous ovarian cancer patients using a somatic multigene panel 130
Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: A case-control study on survival in patients with two year follow-up 127
Impact of bevacizumab containing first line chemotherapy on recurrent disease in epithelial ovarian cancer: A case-control study 127
Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance 126
Minimally invasive versus standard laparotomic interval debulking surgery in ovarian neoplasm: A single-institution retrospective case-control study 126
Learning curve and pitfalls of a laparoscopic score to describe peritoneal carcinosis in advanced ovarian cancer 125
Risk of postoperative pelvic abscess in major gynecologic oncology surgery: one-year single-institution experience 125
Laparoscopy vs. laparotomy for advanced ovarian cancer: a systematic review of the literature 123
Single-Institution Propensity-Matched Study to Evaluate the Psychological Effect of Minimally Invasive Interval Debulking Surgery Versus Standard Laparotomic Treatment: From Body to Mind and Back 122
Feasibility of tumor testing for BRCA status in high-grade serous ovarian cancer using fresh-frozen tissue based approach 121
Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial 119
How to Select Early-Stage Cervical Cancer Patients Still Suitable for Laparoscopic Radical Hysterectomy: a Propensity-Matched Study 118
Ultrasound and color power Doppler in the detection of metastatic omentum: a prospective study 117
Role of different approaches to the abdominal retroperitoneum for aortic lymphadenectomy in patients with gynecological cancers 117
Prognostic Significance of Ultrasound Characteristics and Body Mass Index in Patients with Apparent Early-Stage Cervical Cancer: A Single-Center, Retrospective, Cohort Study 116
Arterial-enteric fistula after pelvic lymphadenectomy in secondary cytoreductive surgery for recurrent ovarian cancer 116
Validation of tumour-free distance as novel prognostic marker in early-stage cervical cancer: a retrospective, single-centre, cohort study 116
Building a personalized medicine infrastructure for gynecological oncology patients in a high-volume hospital 116
Cytoplasmic expression of oestrogen receptor beta (ERβ) as a prognostic factor in vulvar squamous cell carcinoma in elderly women. 115
Targeting the hallmarks of ovarian cancer: The big picture 114
Douglas peritonectomy compared to recto-sigmoid resection in optimally cytoreduced advanced ovarian cancer patients: analysis of morbidity and oncological outcome 113
Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): A feasibility study 113
Beyond sentinel node algorithm. Toward a more tailored surgery for cervical cancer patients 113
Spliceogenic analysis of BRCA1 c.439T>C (rs794727800) variant by High Resolution Melting Analysis 113
Perioperative outcomes of laparoendoscopic single-site surgery (LESS) versus conventional laparoscopy for adnexal disease: a case--control study 112
Pathologic response to neoadjuvant chemotherapy in advanced ovarian cancer: utility of a scoring system to predict outcomes 112
Prognostic Factors for Surgical Failure in Malignant Bowel Obstruction and Peritoneal Carcinomatosis 112
Infiltrating T lymphocytes and programmed cell death protein-1/programmed death-ligand 1 expression in endometriosis-associated ovarian cancer 112
Epithelial ovarian cancer and brain metastases: might the BRCA status, PARP inhibitor administration, and surgical treatment impact the survival? 110
Deep-Learning to Predict BRCA Mutation and Survival from Digital H&E Slides of Epithelial Ovarian Cancer 110
Simple conization and lymphadenectomy for the conservative treatment of stage IB1 cervical cancer. An Italian experience 110
Salvage lymphadenectomy in recurrent ovarian cancer patients: Analysis of clinical outcome and BRCA1/2 gene mutational status 110
Diet and Chemotherapy: The Effects of Fasting and Ketogenic Diet on Cancer Treatment 110
Telelap ALF-X vs Standard Laparoscopy for the Treatment of Early-Stage Endometrial Cancer: A Single-Institution Retrospective Cohort Study 108
One-Step Nucleic Acid Amplification (OSNA): A fast molecular test based on CK19 mRNA concentration for assessment of lymph-nodes metastases in early stage endometrial cancer 108
BRCA testing delay during the COVID-19 pandemic: How to act? 108
Surgical treatment of “large uterine masses” in pregnancy: A single-center experience 108
Ovarian cancer onset across different BRCA mutation types: a view to a more tailored approach for BRCA mutated patients 107
The role of liquid based cytology and ancillary techniques in the peritoneal washing analysis: Our institutional experience 107
Robotic versus laparoscopic radical hysterectomy in early cervical cancer: A case matched control study 107
Comparison of minimally invasive surgery with laparotomic approach in the treatment of high risk endometrial cancer: A systematic review 107
BRCA status and platinum sensitivity in advanced ovarian cancer according to Chemotherapy Response Score 106
BRCA testing on buccal swab to improve access to healthcare and cancer prevention: A performance evaluation 106
Robotic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective Phase II Study 106
Robotic treatment of colorectal endometriosis: technique, feasibility and short-term results 105
The new robotic TELELAP ALF-X in gynecological surgery: single-center experience 105
Role of Intraoperative Ultrasound to Extend the Application of Minimally Invasive Surgery for Treatment of Recurrent Gynecologic Cancer 105
Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer? 105
European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery 105
Pd-l1 expression on circulating tumour-derived microvesicles as a complementary tool for stratification of high-grade serous ovarian cancer patients 105
Surgical outcomes of diaphragmatic resection during cytoreductive surgery for advanced gynecological ovarian neoplasia: A randomized single center clinical trial - DRAGON 105
Sentinel lymph node detection in endometrial cancer with indocyanine green: laparoscopic versus robotic approach 104
TELELAP ALF-X Robotic-assisted Laparoscopic Hysterectomy: Feasibility and Perioperative Outcomes 103
Resectability and Vascular Management of Retroperitoneal Gynecological Malignancies: A Large Single-institution Case-Series 103
Tolerability of bevacizumab in elderly ovarian cancer patients (Turbo study): A case-control study of a real-life experience 103
The impact of hysterectomy on oncological outcomes in postmenopausal patients with borderline ovarian tumors: A multicenter retrospective study 102
Clinical outcome of recurrent locally advanced cervical cancer (LACC) submitted to primary multimodality therapies 102
Prognostic role of metastasis tumor antigen 1 in patients with ovarian cancer: a clinical study 101
Totale 14.702
Categoria #
all - tutte 164.846
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 164.846


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021979 0 0 0 0 0 66 197 50 192 115 295 64
2021/20222.584 172 118 31 255 103 67 97 431 123 151 447 589
2022/20235.646 747 716 452 765 384 729 274 401 689 98 244 147
2023/20243.296 118 886 103 287 102 372 225 125 74 193 351 460
2024/20257.133 157 134 528 235 516 295 292 304 1.036 944 1.496 1.196
2025/202610.716 2.673 534 1.159 2.101 3.521 728 0 0 0 0 0 0
Totale 35.981